The Spanish Presidency of the Council of the European Union organise a European high-level conference to reflect the influence of Personalised Medicine in the evolution of healthcare to improve people’s lives.
The conference will bring together a large number of high-level experts and stakeholders with different background and expertise, from different types of organisations and countries, including from outside Europe, to discuss challenges and opportunities in the field of genomic-based personalised medicine, as well as aspects not covered in research and funding.
Organised by the Spanish Foundation for Science and Technology (FECYT), on behalf of the Spanish Ministry of Science and Innovation, the Institute of Health Carlos III (ISCIII) and the Centre for the Development of Technology and Innovation (CDTI), the conference will take place in the Príncipe Felipe Research Center Foundation (CIPF), host institution of the event.
The term Personalised Medicine (PM) was defined, by the H2020 Advisory Group and EU Health Ministers in 2015, as a “medical model using characterisation of individuals’ phenotypes and genotypes for tailoring the right therapeutic strategy for the right person at the right time, and/or to determine the predisposition to disease and/or to deliver timely and targeted prevention.” During the last years, it has become evident that more and better personalised approaches in medicine and healthcare are needed for prevention, diagnostics and treatment and so several EU policies and initiatives concur with the need that funding and research are required for pushing forward this complex field. Personalised Medicine and Personalised Healthcare have been highlighted as a health horizontal priority in the Horizon Europe Strategic Plan 2021-2024 and a main area for international cooperation. PM is on the backbone of several initiatives for building the European Health Union, in which all EU countries prepare and respond together to health crises, medical supplies are available, affordable and innovative, and countries work together to improve prevention, treatment and aftercare for diseases such as cancer.